{"id":"W2405943329","doi":"10.1007/s10637-016-0364-5","title":"A phase II trial of the BCL-2 homolog domain 3 mimetic AT-101 in combination with docetaxel for recurrent, locally advanced, or metastatic head and neck cancer","year":2016,"lang":"en","type":"article","venue":"Investigational New Drugs","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":43,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto","funders":"National Institute of Dental and Craniofacial Research; National Institute on Deafness and Other Communication Disorders; National Cancer Institute; Foundation for the National Institutes of Health","keywords":"Docetaxel; Medicine; Oncology; Internal medicine; Clinical endpoint; Head and neck squamous-cell carcinoma; Head and neck cancer; Radiation therapy; Cancer; Clinical trial; Phases of clinical research; Chemotherapy; Surgery","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007456256,0.001128272,0.002009296,0.0004240563,0.0004005152,0.001173874,0.001064302,0.001056115,0.003510546],"category_scores_gemma":[0.0004923168,0.0004868363,0.0009277199,0.0004858363,0.00110061,0.0009190254,0.0002954649,0.003654477,0.0008234657],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00121286,"about_ca_system_score_gemma":0.001465478,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002193025,"about_ca_topic_score_gemma":0.007718654,"domain_scores_codex":[0.9997707,0.00008632133,0.000009052796,0.00003897548,0.00002291254,0.00007206187],"domain_scores_gemma":[0.9997084,0.00005039857,0.00003327532,0.00002832258,0.00001282104,0.0001668267],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5841458,0.0815233,0.005350489,0.001582042,0.002263056,0.0008363189,0.0005648575,0.007538563,0.09421403,0.001648716,0.01118211,0.2091506],"study_design_scores_gemma":[0.4875349,0.4861346,0.007875226,0.00005991636,0.0006539613,0.0006619505,0.0001447589,0.002930647,0.00725117,0.0004656065,0.006222175,0.00006499625],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.99006,0.002733163,0.0005296821,0.0006924759,0.0003261828,0.001454758,0.0007288164,0.0001416495,0.003333299],"genre_scores_gemma":[0.9887803,0.002546663,0.001029425,0.0006329168,0.0001246237,0.001081977,0.001373576,0.00003359954,0.004396976],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003510546,"threshold_uncertainty_score":0.0117439,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01848131406365525,"score_gpt":0.2890376702067251,"score_spread":0.2705563561430698,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}